Influence of tumor microenvironment on the different breast cancer subtypes and applied therapies

• Type: Another Publication in an International Scientific Journal
• Date: 2024

Authors

Almeida, CF (Author) Other; Georgina Correia da Silva (Author) FFUP; Teixeira, N (Author) Other; Amaral, C (Author) Other

Journal

Title: Biochemical Pharmacology

Vol. 223

ISSN: 0006-2952

Publisher: Elsevier

Indexing

ISI Web of Knowledge - 0 Citations

Scopus - 0 Citations

Other information

Authenticus ID: P-010-91M

DOI: 10.1016/j.bcp.2024.116178

Abstract (EN): Despite the significant improvements made in breast cancer therapy during the last decades, this disease still has increasing incidence and mortality rates. Different targets involved in general processes, like cell proliferation and survival, have become alternative therapeutic options for this disease, with some of them already used in clinic, like the CDK4/6 inhibitors for luminal A tumors treatment. Nevertheless, there is a demand for novel therapeutic strategies focused not only on tumor cells, but also on their microenvironment. Tumor microenvironment (TME) is a very complex and dynamic system that, more than surrounding and supporting tumor cells, actively participates in tumor development and progression. During the last decades, it has become clear that the cellular and acellular components of TME differ between the various breast cancer subtypes and shape the differences regarding their severity and prognosis. The pivotal role of the TME in controlling tumor growth and influencing responses to therapy represents a potential source for novel targets and therapeutic strategies. In this review, we present a description of the multiple therapeutic options used for different breast cancer subtypes, as well as the influence that the TME may exert on the development of the disease and on the response to the distinct therapies, which in some cases may explain their failure by the occurrence of relapses and resistance. Furthermore, the ongoing studies focused on the use of TME components for developing potential cancer treatments are described.

Language: English

Type (Professor's evaluation): Scientific

No. of pages: 18